In order to punish figure skater Kamilia Valeiva, the Russian Anti-Doping Agency has requested that the Court of Arbitration for Sport reverse Rusada’s own decision.
Prior to a positive drug test in December 2021, Rusada determined Valieva had “no blame or negligence.”
Both the Russians and the World Anti-Doping Agency (Wada) have now appealed that ruling to Cas.
For the 2022 Winter Games, the discovery of the positive test result led to a heated debate.
“Rusada requests a verdict from Cas setting aside the challenged decision and declaring the athlete to have violated the Rusada anti-doping rules, and sanctioned with “the relevant consequences,” ” Cas stated on Friday.
Rusada expressed the hope that the Cas decision “may contain or be limited to a reprimand.”
Moreover, Cas acknowledged that the International Skating Union (ISU) had appealed Rusada’s decision finding Valieva not guilty.
In December 2021, Valieva, who was 15 at the time, failed a drug test in the Russian national championship after testing positive for the outlawed cardiac medication trimetazidine.
Details of the outcome didn’t come to light until after she had won gold in the team competition at the Beijing Games in February 2022, where she made Olympic history by becoming the first woman to land a quadruple leap.
Once a court lifted her temporary suspension, she was permitted to participate in the women’s singles competition.
She left the arena in tears, having slipped from first to fourth after a succession of missteps and crashes.
For the 16-year-old, Wada is asking for a four-year suspension, while the ISU is asking for “a term of ineligibility at Cas’ discretion” starting on December 25, 2021, and “disqualification of all achievements obtained during this period including forfeiture of any medals, points, and rewards.”